A draft genome of Escherichia coli sequence type 127 strain 2009-46 by unknown
Darling et al. Gut Pathogens 2014, 6:32
http://www.gutpathogens.com/content/6/1/32
GENOME ANNOUNCEMENT Open Access
A draft genome of Escherichia coli sequence
type 127 strain 2009-46
Aaron E Darling1*†, Jessica McKinnon1†, Paul Worden1, Jerran Santos1, Ian G Charles1,
Piklu Roy Chowdhury1,2 and Steven P Djordjevic1
Abstract
Background: Escherichia coli are a frequent cause of urinary tract infections (UTI) and are thought to have a
foodborne origin. E. coli with sequence type 127 (ST127) are emerging pathogens increasingly implicated as a cause of
urinary tract infections (UTI) globally. A ST127 isolate (2009-46) resistant to ampicillin and trimethoprim was recovered
from the urine of a 56 year old patient with a UTI from a hospital in Sydney, Australia and was characterised here.
Results: We sequenced the genome of Escherichia coli 2009-46 using the Illumina Nextera XT and MiSeq
technologies. Assembly of the sequence data reconstructed a 5.14 Mbp genome in 89 scaffolds with an N50 of
161 kbp. The genome has extensive similarity to other sequenced uropathogenic E. coli genomes, but also has several
genes that are potentially related to virulence and pathogenicity that are not present in the reference E. coli strain.
Conclusion: E. coli 2009-46 is a multiple antibiotic resistant, phylogroup B2 isolate recovered from a patient with a
UTI. This is the first description of a drug resistant E. coli ST127 in Australia.
Keywords: Escherichia coli 2009-46, Genome, Sequencing
Background
Escherichia coli infections of the urinary tract are among
the most frequent infections reported in the developed
world with an estimated 130-175 million cases per annum
worldwide [1]. E. coli that cause urinary tract infections
(UTI) are classified as uropathogenic Escherichia coli
(UPEC), a subgroup of extraintestinal pathogenic E. coli
(ExPEC). ExPEC also cause a range of afflictions including
meningitis, septicaemia, and pneumonia and are genotyp-
ically and phenotypically distinct from diarrhoegenic E.
coli (DEC) [2]. ExPEC are thought to be acquired orally
via the consumption of contaminated food and are con-
sidered to be zoonotic pathogens [3-5]. The emergence of
multiple antibiotic resistance among ExPEC poses a seri-
ous health threat; antibiotics are an important treatment
strategy for controlling UTI.
Multilocus sequence typing (MLST) is currently the
gold standard for characterising E. coli causing UTI.
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No clear diagnostic markers are available for identi-
fying E. coli causing UTI, but several sequence types
(ST) including ST131, ST405, ST95, ST65, ST127, and
ST10 are recognised UTI pathogens [6]. ExPEC ST127
are described as community-acquired and highly viru-
lent zoonotic pathogens [3,6] but to our knowledge there
are no genome sequences representing antibiotic resis-
tant isolates of this emerging pathogen. Studies of E. coli
causing UTI in Australia have focussed on characteris-
ing ST131 [7,8] and serogroup O75 isolates belonging to
clonal complex 14 [9].
Here we describe the genome sequence of E. coli ST127
isolate 2009-46, a mid-stream urinary tract isolate from
a 56 year old patient from the Sydney Adventist Hospital
(SAN clinic) resistant to ampicillin and trimethoprim.
Methods
The isolate was supplied on a Sensi-agar plate from the
SAN laboratories in Sydney, Australia. To confirm pure
culture, a loopful of the isolate was streaked onto a Luria
Bertani (LB) Agar plate and incubated at 37°C for long
term storage in minus 80°C as a glycerol stock. A sin-
gle colony was picked from the plate and subcultured in
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10 mL LB broth at 37°C overnight. To prepare the glycerol
stock culture 7mL of the overnight was used, and genomic
DNA was prepared from the remaining 3 mL. Genomic
DNA for sequencing was prepared using the ISOLATE II
gDNA extraction kit from Bioline.
Genome sequencing
DNA was quantified using qubit flourimetry and 0.5 ng of
gDNA was used as template to construct the sequencing
library, using the Illumina Nextera XT library prepara-
tion protocol following the manufacturer’s instructions.
However, the “PCR Clean-Up” and “Library Normaliza-
tion” steps were omitted and size selection was instead
performed by running balanced and pooled samples in a
1% agarose gel and excising the 600 bp to 1200 bp region
of interest. The DNA was then purified from the agarose
using Promega’s Wizard SV Gel and PCR Clean-Up Sys-
tem. Finally, an Agilent 2100 Bioanalyzer, with a High
Sensitivity DNA Kit, was used to quantitate the pooled
DNA library before loading onto the MiSeq with other
multiplexed samples. Two MiSeq runs were carried out,
one with paired-end 250 nt reads on MiSeq V2 chem-
istry and another with paired-end 300 nt reads on V3
chemistry. The first library was found to have an average
insert size of 368+/− 157 nt, while the second library had
inserts with an average size 497 +/− 118 nt.
Assembly and annotation
The genome was assembled using the A5-miseq pipeline,
a version of the A5 pipeline [10] that has been revised
to process reads up to 500 nt long. Briefly, the A5-miseq
pipeline consists of five stages: (1) read quality filtering
and error correction, (2) contig assembly, (3) permissive
draft scaffolding, (4) misassembly detection, and (5) con-
servative scaffolding. The revised A5 pipeline uses a new
version of idba_ud that uses read pairing information,
and that has been modified to accept reads up to 500 nt
long and to construct de Bruijn graphs with k-mers up to
500 nt. These modifications provide substantial improve-
ments in assembly contiguity.
The genome was annotated with the RAST annotation
system using FigFAM release 70 [11]. Putative antibiotic
resistance genes and other genes of interest identified by
RAST annotation were manually curated using the NCBI
ORF finder and iterative BLASTn and BLASTp searches.
Quality assurance
The A5 pipeline includes a quality checking step that
detects putative misassemblies by identifying clusters of
read pairs that map to disjoint locations in the assem-
bled genome. This method did not detect any putative
misassemblies.
Initial findings
Sequencing generated 1,702,236 read pairs for a total of
483,658,987 nt that were assembled to reconstruct the
5,139,229 bp genome of E. coli 2009-46 in 89 scaffolds,
with a scaffold N50 of 161 kbp and anN90 of 30.8 kbp. The
raw (unfiltered) coverage is 94x, and after read filtering
the assembly has a median depth of coverage of 61x. The
annotation of this assembly identified 5084 predicted CDS
and 106 predicted RNA genes. 19 genes were identified
as possibly missing from the assembly by the RAST sys-
tem. The overall functional profile of the genome is shown
Figure 1 Subsystems in E. coli 2009-46.
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in Figure 1. We conducted a phylogenetic analysis of E.
coli 2009-46 using the PhyloSift software [12] to identify
the most closely related organism with an available refer-
ence genome. PhyloSift works by identifying homologs in
the draft genome to a set of 37 genes that are universally
conserved among bacteria and archaea and present in sin-
gle copy. It then adds any homologs found in the draft
genome to an existing multiple sequence alignment con-
taining the 37 genes from a subset of all genomes publicly
available in the NCBI and EBI databases that is chosen
to span the phylogenetic diversity of these databases. The
PhyloSift reference database includes only a single rep-
resentative from groups of closely related organisms. To
gain additional resolution in the Escherichia, we used Phy-
loSift to construct a multiple alignment of the 37 marker
genes from all finished E. coli genomes available in the
NCBI database as of September 2013. We then inferred a
phylogeny from that alignment using FastTree2 [13]. The
resulting analysis, shown in Figure 2, identified E. coli 536
as the most closely related isolate with a finished genome
available, although there was some uncertainty in the 37
gene alignment as to whether E. coli 2009-46 diverged
on the same lineage as E. coli 536. We used the closely
related genome of E. coli 536 as a reference for further
comparative analysis.
The scaffolds of E. coli 2009-46 were reordered to match
the order in the finished genome of the closely related
strain E. coli 536 using the Mauve Contig Mover [14].
After reordering, the genomes had 82 predicted rear-
rangement breakpoints. Many of these cluster in regions
containing annotated transposase genes and multi-copy
transporter gene families, suggesting either homology-
mediated rearrangement or misassembly has occurred
at these repetitive sequences. To further characterize
the structure of the genome we used the CGview web-
server [15] to plot matches to annotated proteins and the
GC skew of the genome, with scaffolds ordered accord-
ing to the E. coli 536 reference. The CGview plot is shown
Figure 2 Phylogeny of E. coli and Shigella including the 2009-46 isolate. A phylogeny inferred on a concatenated set of codon alignments
from 37 universally conserved genes is shown, as calculated by PhyloSift [12] and FastTree2 [13]. The phylogeny has been rooted on the branch
leading to Salmonella and internal nodes are labeled with SH-like support values.
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in Figure 3. Of note, the GC skew in E. coli 2009-46
genome appears to fluctuate frequently. This pattern is in
sharp contrast to the GC skew of the E. coli 536 reference,
which shows a strong pattern coinciding with the chro-
mosome’s replication arms (data not shown). This sug-
gests that either E. coli 2009-46 has undergone substantial
genome rearrangement in the recent past, that the true
genome arrangement may not match the E. coli 536 ref-
erence very closely, that undetectable misassembly errors
exist in the E. coli 2009-46 genome, or that some combi-
nation of these three situations exists. We note that our
assembly pipeline contains a step to detect and fix misas-
sembly errors; none were found in the genome of E. coli
2009-46.
Comparison of the gene content between E. coli 2009-
46 and the finished E. coli 536 reference genome identified
164 annotated gene functions predicted to be present only
in E. coli 2009-46. Included among these are several genes
related to scavenging iron, a type VII secretion system,
an IncF conjugation system,mediators of hyperadherence,
and copper and mercury resistance genes. The full list of
gene functions found only in 2009-46 and those which
2009-46 lacks relative to the reference isolate are listed in
Additional files 1 and 2, respectively.
The blaTEM1 gene, conferring resistance to ampicillin,
was present on scaffold 78.1 (2551 nt), while the sul2-
strA-strB genes conferring resistance to sulphonamides
and streptomycin was located on scaffold 67.1, which was
5064 nt long. Ends of both the scaffolds had a partial
copy the insertion element IS26. The isolate also houses
a clinical class 1 integron and two associated resistance
genes on scaffold 71.1. One of the two resistance genes
is a variant of dihydrofolate reductase (dhfr) gene which
provides trimethoprim resistance to isolates and the other
confers resistance to aminoglocoside antibiotics (aadA).
However the scaffold, 71.1, is 3,863 nt long and also has a
copy of IS26 at both ends. We identified the presence of
the 3’-CS of a class 1 integron on scaffold 58.1 (6679 nt
long), that had an IS26 on one end and an IS1 element
on the other. Presence of IS26 elements at both ends of
seven scaffolds has resulted in scaffold breaks around a
region of the genome, which most likely harbours a com-
plex resistance locus (CRL), during the assembly of the
genome sequence. We were therefore unable to confirm
Figure 3 CGview plot of the E. coli 2009-46 genome. The two outermost circles in the figure contain a series of arrows in opposite directions
representing predicted ORFs (greater than 100 codons) on the two strands of DNA sequence. The solid line, forming the third ring (from outside)
indicates BLASTn analysis (set with a cutoff of 1e-10) of the isolate against the E. coli 536 genome. Relative GC content along the length of the
genome is plotted as a graph in the black circle. The GC content clearly indicates multiple regions of GC content variation along the genome,
possibly indicating lateral gene transfer events.
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the exact genomic location of the CRL or resistance
genes.
Antibiotic resistance profile
The antibiotic resistance profile of E. coli 2009-46
was experimentally determined using the disk diffusion
method. This strain was found to be resistant to Ampi-
cillin, Trimethoprim, Sulphafurazole, Tetracycline, Strep-
tomycin, Apramycin, Kanamycin, and Azithromycin. A
full list of antibiotics tested and E. coli 2009-46 suscepti-
bility is provided in Additional file 3.
To better understand the genomic basis for the observed
antibiotic resistance traits, the genome was searched for
specific genes known to confer antibiotic resistance. A list-
ing of these genes and their presence or absence in E. coli
2009-46 is provided in Additional file 3.
Future directions
Improved efficiency of clinical genomics pipelines will
eventually enable fine-scale epidemiological monitoring
of E. coli outbreaks in real time. When fully developed,
this capacity will influence clinical and public health deci-
sions related to treatment and control of pathogen out-
breaks. Genomic data such as is presented here will aid in
the interpretation of data from future outbreaks.
Availability of supporting data
The draft genome assembly has been submitted to
NCBI and is associated with BioSample accession
SAMN02725027. Genome annotations are available from
the RAST web server under accession 562.3620. The
Illumina sequence reads have been deposited to the
Short Read Archive under accessions SRX514806 and
SRX514807.
CDS: Coding DNA sequences; ORF: Open Reading
frame; RAST: Rapid annotation using subsystem technol-
ogy; A5: Andrew and Aaron’s Awesome Assembly; gDNA:
genomic DNA; nt: Nucleotides.
Additional files
Additional file 1: Gene functions (as identified by RAST subsystems)
found to be present in the newly sequenced E. coli 2009-46 isolate
but not the E. coli 546 reference genome.
Additional file 2: Gene functions (as identified by RAST subsystems)
found to be present only in the E. coli 546 reference genome in a
pairwise comparison with E. coli 2009-46.
Additional file 3: Details on PCR cartography, virulence gene
searches, and antibiotic resistance assays.
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